Business Context and Reporting Period
This Form 8-K filing by BioRestorative Therapies, Inc. (Nevada) covers events occurring on June 27, 2014, with the report dated July 3, 2014. The filing primarily addresses changes in the composition of the Board of Directors and associated compensatory arrangements.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and equity compensation events rather than financial performance.
Material Changes
- Director Resignation: Joel San Antonio resigned as a director on June 27, 2014, citing other business commitments.
- Director Elections: Paul Jude Tonna and Joseph B. Swiader were elected as directors on June 27, 2014.
- Committee Appointments:
- Mr. Tonna was appointed to the Audit, Compensation, and Nominating Committees.
- Mr. Swiader was appointed to the Compensation and Nominating Committees.
- Equity Compensation: Both new directors were granted options to purchase 300,000 shares each under the 2010 Equity Participation Plan.
- Exercise Price: $0.285 per share.
- Vesting Schedule: 100,000 shares vest immediately, 100,000 on the first anniversary, and 100,000 on the second anniversary.
- Term: Options are exercisable for ten years.
Guidance, Outlook, and Risks
The filing does not contain management guidance, financial outlook, or specific risk factors beyond the standard disclosure of the equity plan provisions. The company issued press releases on June 30, 2014, and July 2, 2014, to announce the elections of Mr. Tonna and Mr. Swiader, respectively.
Investor Verification Checklist
- Verify the current status of the 2010 Equity Participation Plan to ensure sufficient shares remain available for the 600,000 new options granted.
- Confirm the independence status of the new directors, particularly Mr. Tonna's appointment to the Audit Committee.
- Review the press releases (Exhibits 99.1 and 99.2) for additional biographical details on the new directors.
- Check subsequent filings for any changes to the vesting schedule or exercise price due to corporate actions.